We seek to back companies and management teams whose innovation stands to redefine the standard of care. Combining deep sector research with clinical, commercial and strategic judgment, we invest at the stage where value can most consistently be realized — aiming to advance scientific and technological progress into treatments and devices that improve patients’ lives.
